Clinical Trial Update: Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients

View source ↗

Summary

The clinical trial evaluating early dietary lysine restriction in patients with pyridoxine-dependent epilepsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyridoxine-dependent Epilepsy

Snippet

Sponsor: University of British Columbia | Conditions: Pyridoxine Dependant Epilepsy | Status: WITHDRAWN